mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.8 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.8 |